维普期刊资源整合服务平台（V6.5）

67篇 您的检索式：作者名="Fanale"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	The Role of MedicationNoncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly显示文摘	Col N Fanale J E Kronholm P	1990	Arch Intern Med1990，150，4：	1
2	Preliminary report ofmulticenter prospective phase D study of DA-EPOCH-R inmycrearranged aggressive B-cell lymphoma 显示文摘	Dunleavy K Fanale M Lacasce A	2014	ASH AnnualMeeting2014，，：	1
3	Final report of a phase-II study of rituximab plus ABVD for patients with newly diagnose advanced stage classical Hodgkin's Lymphoma:Results of long follow up and comparison to institutional historical data显示文摘	Copeland AR Cao Y Fanale M	2009	Blood2009，114，：	1
4	Enantioselective determination by capillary electrophoresis with cyclodextrins as chiral selector显示文摘	FANAL I S	2000	J Chromatogr A2000，875，：	1
5	A phase Iweekly dosing study of brentuximab vedotin in patients withrelapsed/refractory CD30-positive hematologic malignancies 显示文摘	Fanale MA Forero-Torres A Rosenblatt JD	2012	Clin Cancer Res2012，18，：	1
6	A phase I weekly dosing study of brentuximab vedotin in patients with re- lapsed/refractory CD30-positive hematologic malignancies 显示文摘	Fanale MA Forero-Torres A Rosenblatt JD	2012	Clin Cancer Res2012，18，1：	1
7	A phase I week- ly dosing study of brentuximab vedotin in patients with relapsed/ refractory CD30-positive hematologic malignancies显示文摘	Fanale MA Forero-Torres A Rosenblatt JD	2012	Clin Can- cer Res2012，18，1：	1
8	A randomizedtrial of a single-dose rasburicase versus five-daily doses inpatients at risk for tumor lysis syndrome 显示文摘	Vadhan-Raj S Fay ad LE Fanale MA	2012	Ann Oncol2012，23，6：	1
9	Acute respiratory distress syndrome:update on the latest developments in the basic and clinical research显示文摘	Bosma K Fanalli V Ranieri AM	2005	Cur Opin Anaesthes2005，18，2：	1
10	Retreatment with brentux- imab vedotin in patients with CD30-positive hematologic malig- nancies显示文摘	Bartlett NL Chen R Fanale MA	2014	J Hematol Oncol2014，7，1：	1
11	Defining a population of HodgKin's Lymphoma显示文摘	Horning S Fanale M Devos S	2007	Blood2007，110，10：	1
12	Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma显示文摘	Michelle Fanale Luis Fayad Barbara Pro Felipe Samaniego Mary Joy Liboon Cesar Nunez Sandra Horowitz Paolo Anderlini Uday Popat Yuan Ji Larry W. Kwak Anas Younes	2011	British Journal of Haematology2011，，：	1
13	Phase I study of bortezomib plus ICE(BICE)for the treatment of relapsed/refractory Hodgkin lymphoma显示文摘	Fanale MA Fayad LE Pro B	2011	Br J Heamotol2011，153，：	1
14	The role of medication noncompliance and adverse drug reactions in hospitalisations of the elderly显示文摘	Col N Fanale JE Kronholm P	1990	Archives of Internal Medicine1990，150，4：	1
15	Isotype-selective HDAC inhibitor MGCD0103 decreases serum TARC concentrations and produces clinical responses in heavily pretreated patients with relapsed classical Hodgkin lymphoma(HL)显示文摘	Younes A Pro B Fanale M	2007	Blood2007，110，11：	1
16	Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment显示文摘	Fanale M	2013	Hematology Am Soc Hematol Educ Pro- gram2013，2013，：	1
17	Final report of a phase-II study of rituximab plus ABVD for patients with newly diagnosed advanced stage classical Hodgkin Lymphoma:Results of long follow up and comparison to institutional historical data显示文摘	Copeland AR Cao Y Fanale M	2009	Blood2009，114，8：	1
18	Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy显示文摘	Fanale MA Uyei AR Theriault RL	2005	Clin Breast Cancer2005，6，4：	1
19	HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions显示文摘	Fanale D Bazan V Corsini L R	2013	Breast Cancer Research and Treatment2013，140，3：	1
20	Combination therapy of Ad-mda-7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells显示文摘	MoKENZIE T LIU Y FANALE M	2004	Surgery2004，136，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示